201
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Assessment of safety of performing percutaneous coronary intervention after a recent episode of gastrointestinal bleeding

, , , , , & show all
Pages 1-6 | Received 24 Apr 2015, Accepted 22 Sep 2015, Published online: 27 Oct 2016

References

  • Manzano-Fernandez S, Marin F, Martinez JA, Cambronero F, Valdes M, Ruiz-Nodar JM, et al. Anaemia as predictor of gastrointestinal bleeding in atrial fibrillation patients undergoing percutaneous coronary artery stenting. QJM 2008;101:749–51.
  • Steinberg DH, Shah P, Kinnaird T, Pinto Slottow TL, Roy PK, Okabe T, et al. Bleeding risk and outcomes of bivalirudin versus glycoprotein IIb/IIIa inhibitors with targeted low-dose unfractionated heparin in patients having percutaneous coronary intervention for either stable or unstable angina pectoris. Am J Cardiol. 2008;102:160–4.
  • Overgaard CB, Ivanov J, Seidelin PH, Todorov M, Mackie K, Dzavik V. Thrombocytopenia at baseline is a predictor of inhospital mortality in patients undergoing percutaneous coronary intervention. Am Heart J. 2008;156:120–4.
  • Younossi ZM, Strum WB, Schatz RA, Teirstein PS, Cloutier DA, Spinks TJ. Effect of combined anticoagulation and low-dose aspirin treatment on upper gastrointestinal bleeding. Dig Dis Sci. 1997;42:79–82.
  • Lin S, Konstance R, Jollis J, Fisher DA. The utility of upper endoscopy in patients with concomitant upper gastrointestinal bleeding and acute myocardial infarction. Dig Dis Sci. 2006;51:2377–83.
  • Chin MW, Yong G, Bulsara MK, Rankin J, Forbes GM. Predictive and protective factors associated with upper gastrointestinal bleeding after percutaneous coronary intervention: A case-control study. Am J Gastroenterol. 2007;102:2411–6.
  • Abbas AE, Brodie B, Dixon S, Marsalese D, Brewington S, O’Neill WW, et al. Incidence and prognostic impact of gastrointestinal bleeding after percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol. 2005;96:173–6.
  • Dai X, Makaryus AN, Makaryus JN, Jauhar R. Significant gastrointestinal bleeding in patients at risk of coronary stent thrombosis. Rev Cardiovasc Med. 2009; 10:14–24.
  • Norgard NB, Mathews KD, Wall GC. Drug–drug interaction between clopidogrel and the proton pump inhibitors. Ann Pharmacother. 2009;43:1266–74.
  • van Werkum JW, ten Berg JM, Bredenoord AJ. Proton pump inhibitors and clopidogrel: A difficult dilemma. Am Heart J. 2009;157:e43; e45.
  • Sibbing D, Morath T, Stegherr J, Braun S, Vogt W, Hadamitzky M, et al. Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel. Thromb Haemost. 2009;101:714–9.
  • Ho PM, Maddox TM, Wang L, Fihn SD, Jesse RL, Peterson ED, et al. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA 2009;301:937–44.
  • Gilard M, Arnaud B, Cornily JC, Le Gal G, Lacut K, Le Calvez G, et al. Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: The randomized, double-blind OCLA (omeprazole clopidogrel aspirin) study. J Am Coll Cardiol. 2008;51:256–60.
  • Tan VP, Yan BP, Kiernan TJ, Ajani AE. Risk and management of upper gastrointestinal bleeding associated with prolonged dual-antiplatelet therapy after percutaneous coronary intervention. Cardiovasc Revasc Med. 2009;10:36–44.
  • Aronow HD, Steinhubl SR, Brennan DM, Berger PB, Topol EJ. Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the clopidogrel for the reduction of events during observation (CREDO) trial. Am Heart J. 2009;157:369–74.
  • Foley P, Foley S, Kinnaird T, Anderson RA. Clinical review: Gastrointestinal bleeding after percutaneous coronary intervention: A deadly combination. QJM 2008;101:425–33.
  • Yachimski P, Hur C. Upper endoscopy in patients with acute myocardial infarction and upper gastrointestinal bleeding: Results of a decision analysis. Dig Dis Sci. 2009;54:701–11.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.